Skip to content

Odd Erik Johansen

Boehringer Ingelheim (Norway)

1 paper in the Anchorcite directory, published in 2015, cited 12,596 times in total.

ORCID profile

Research topics

Frequent co-authors

  • Bernard Zinman · 1 paper
  • Christoph Wanner · 1 paper
  • John M. Lachin · 1 paper
  • DAVID H. FITCHETT · 1 paper
  • Erich Bluhmki · 1 paper
  • Stefan Hantel · 1 paper
  • Michaela Mattheus · 1 paper
  • Theresa Devins · 1 paper

Papers

  1. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 DiabetesNew England Journal of Medicine · 2015 · 12,596 citations

    BACKGROUND: The effects of empagliflozin, an inhibitor of sodium-glucose cotransporter 2, in addition to standard care, on cardiovascular morbidity and mortality in patients with type 2 diabetes at high cardiovascular risk are not known. METHODS: We randomly assigned patients to…

Metadata from OpenAlex (CC0).